| 摘要 |
The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. More specifically, the invention provides appropriately functionalized 5,6-fused bicyclics which inhibit, regulate and/or modulate kinase receptor, particularly c-Met, KDR, and flt-3, signal transduction pathways related to the changes in cellular activities as mentioned above, compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. |
| 申请人 |
EXELIXIS, INC.;BANNEN, LYNNE, CANNE;CHAN, DIVA, SZE-MING;DALRYMPLE, LISA, ESTHER;JAMMALAMADAKA, VASU;KHOURY, RICHARD, GEORGE;LEAHY, JAMES, WILLIAM;MAC, MORRISON, B.;MANN, GRACE;MANN, LARRY, W.;NUSS, JOHN, M.;PARKS, JASON, JEVIOUS;WANG, YONG;XU, WEI |
发明人 |
BANNEN, LYNNE, CANNE;CHAN, DIVA, SZE-MING;DALRYMPLE, LISA, ESTHER;JAMMALAMADAKA, VASU;KHOURY, RICHARD, GEORGE;LEAHY, JAMES, WILLIAM;MAC, MORRISON, B.;MANN, GRACE;MANN, LARRY, W.;NUSS, JOHN, M.;PARKS, JASON, JEVIOUS;WANG, YONG;XU, WEI |
